Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

UCB presents epilepsy research at American Epilepsy Society Annual Meeting

December 9, 2024 Research and Development American Epilepsy Society, Dravet Syndrome, Neurology, UCB, sleep

Belgian-based biopharmaceutical company UCB has announced it will present 32 abstracts at the American Epilepsy Society (AES) Annual Meeting – …
News

Antibacterial peptides instrumental in efficiency against resistant bacteria

November 18, 2024 Research and Development AMR, Chalmers Institute of Technology, Infections and infestations, MRSA, antibacterial peptides

This month, the Chalmers University of Technology in Sweden have published the results of a study demonstrating that resistant bacteria, …
News

Spinal cord stimulator with AI technology receives CE Mark certification

November 13, 2024 Research and Development AI, EU, Nevro, Pain, spinal cord stimulation

The HFC iQ, a personalised spinal cord stimulation (SCS) system developed by Nevro that leverages AI technology to manage chronic …
News

J&J seek approval for first drug to treat high-risk smoldering myeloma

November 13, 2024 Research and Development FDA, J&J, Rare Diseases, bone marrow

Earlier in November, Johnson & Johnson innovative medicine have applied to the US Food and Drug Agency (FDA) and the …
News

Theramex receives recommendation for YSELTY in Scotland

November 11, 2024 Research and Development Pain, Reproductive health, appproval, tumours, women's health

Theramex, a dedicated women’s health company, have announced that the Scottish Medicines Consortium (SMC) have recommended YSELTY (linzagolix) for the …
News

Johnson & Johnson receive MHRA approval for BALVERSA

November 8, 2024 Research and Development J&J Innovative Medicine, Oncology, Urology, bladder cancer

BALVERSA (erdafitinib) has been granted marketing approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment …
News

SolasCure partners with US Army for better wound care technology

November 6, 2024 Research and Development Dressings, hosiery & appliances, Solascare, US army, wound care, wound gel

SolasCure, a biotechnology company which is dedicated to working towards filling the current market gap in debridement – the removal …
News

NorthWest EHealth (NWEH) announces a pilot to test a new model for finding and recruiting participants for clinical trials using the Clinical Practice Research Datalink

November 5, 2024 Research and Development NorthWest Ehealth, clinical trials

The pilot aims to speed up the process for safely and securely finding participants for UK clinical trials, improving efficiencies …
News
Press release

University of Edinburgh spinout Kynos Therapeutics acquired by Dr. Falk Pharma

October 30, 2024 Research and Development Edinburgh, Internal Medicine, Microbiology, acquisitions, biopharma, inhibitors

Kynos Therapeutics – a Scottish clinical stage biopharma company focusing on developing novel kynurenine 3-monooxygenase (KMO) inhibitors – has been …
News

HIV vaccine candidate successfully optimised for industrial production

October 30, 2024 Research and Development HIV, HIV/AIDS, Naobios, Sumagen, Vaccine, agreement

Sumagen Canada Inc, a biotech company based in both South Korea and Canada has partnered with CDMO Naobios to industrialise …
News
cancer_drip_2

Chiesi announces phase 3 results from enzyme-replacement study

October 29, 2024 Research and Development Internal Medicine, Rare Diseases, chiesi Global rare diseases, clinical trials, pharma, rare diseases

Chiesi Global Rare Diseases have announced the results from their BRIGHT trial, which evaluates the efficacy of enzyme-replacement therapy drug …
News

Shawn Cross appointed as chief financial officer for Pacira Biosciences

October 25, 2024 Research and Development Pacira Biosciences

Pacira Biosciences, spcecialist in non-opioid pain therapies, has appointed Shawn Cross as their chief financial officer. In this role, Mr …
Appointment

Stelis, Strides and Steriscience merge to form new CDMO

October 22, 2024 Research and Development CMDO, CPhI, Corporate, bangalore, merger

The CDMO launched earlier this year at the CPHI conference in Milan. The merger is comprised of Stelis Sciences, Strides …
News

Eplontersen recommended for EU approval by CHMP for treatment of hereditary transthyretin-mediated amyloidosis

October 21, 2024 Research and Development CHMP, EMA, EU, Internal Medicine, gene

Wainzua (eplotersen), produced by AstraZeneca and Ionis, has been recommended for approval in the European Union (EU) by the European …
News

Ferring demonstrates effectiveness of a treat-to-target approach in mild-to-moderate ulcerative colitis in first major study

October 3, 2024 Research and Development Ferring Pharmaceuticals, Gastrointestinal tract, ulcerative colitis

1 October 2024 – Saint-Prex, Switzerland – Ferring Pharmaceuticals today announces results from the OPTIMISE study showing the first real-world …
News
Press release
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026